Full-Time
Posted on 6/27/2024
Designs precision biologics using in vivo methods
Senior, Expert
Boston, MA, USA
Manifold Bio focuses on creating precision biologics for the pharmaceutical industry. Their main product is an in vivo drug design platform, which allows for drug testing within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment. This capability is especially beneficial for testing complex biologics, which are large molecule drugs derived from living organisms. Manifold Bio stands out from competitors by being the first to offer this in vivo drug design approach. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.
Company Stage
Series A
Total Funding
$58.8M
Headquarters
Boston, Massachusetts
Founded
2020
Help us improve and share your feedback! Did you find this helpful?